Search Results - "Sjogren, Magnus J.C."

Alzheimer biomarkers and clinical Alzheimer disease were not associated with increased cerebrovascular disease in a memory clinic population by Spies, Petra E, Verbeek, Marcel M, Sjogren, Magnus J C, de Leeuw, Frank-Erik, Claassen, Jurgen A H R

“…Preclinical and post-mortem studies suggest that Alzheimer disease (AD) causes cerebrovascular dysfunction, and therefore may enhance susceptibility to…”
Get more information

Cerebral vascular encephalopathy causes decreased cerebrospinal Aβ concentrations by Verbeek, Marcel M, Spies, Petra E, Slats, Diane, Sjogren, Magnus J.C, Kremer, Berry P.H, Olde Rikkert, Marcel G.M, Greenberg, Steven M

Get full text

Hourly variability of cerebrospinal fluid biomarkers in Alzheimer's disease subjects and healthy older volunteers by Slats, Diane, Claassen, Jurgen A.H.R, Spies, Petra E, Borm, George, Besse, Kees T.C, van Aalst, William, Tseng, Jack, Sjögren, Magnus J.C, Olde Rikkert, Marcel G.M, Verbeek, Marcel M

“…Abstract Large hour-to-hour variability has previously been demonstrated in the cerebrospinal fluid (CSF) concentrations of Alzheimer's disease (AD) biomarkers…”
Get full text

Hourly variability of cerebrospinal fluid biomarkers in Alzheimer patients and healthy elderly controls by Slats, Diane, Spies, Petra E, Claassen, Jurgen A.H.R, Sjögren, Magnus J.C, Tseng, Jack, Verbeek, Marcel M, Olde Rikkert, Marcel G.M

Get full text

Cerebrospinal Fluid Biomarkers in Diagnosing Alzheimer’s Disease in Clinical Practice: An Illustration with 3 Case Reports by Slats, Diane, Spies, Petra E., Sjögren, Magnus J.C., Verhey, Frans R.J., Verbeek, Marcel M., Olde Rikkert, Marcel G.M.

“…Analysis of the brain specific biomarkers amyloid β 42 (Aβ 42 ) and total tau (t-tau) protein in cerebrospinal fluid (CSF) has a sensitivity and specificity of…”
Get full text

O3‐04‐08: Cerebral vascular encephalopathy causes decreased cerebrospinal Aβ concentrations by Verbeek, Marcel M., Spies, Petra E., Slats, Diane, Sjogren, Magnus J.C., Kremer, Berry P.H., Olde Rikkert, Marcel G.M., Greenberg, Steven M.

Get full text

Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders by Spies, Petra E, Melis, René J F, Sjögren, Magnus J C, Rikkert, Marcel G M Olde, Verbeek, Marcel M

“…Alpha-synuclein is the major constituent of Lewy bodies found in neurons in dementia with Lewy bodies (DLB) and might be of diagnostic value as a biomarker for…”
Get more information

Vagus nerve stimulation in patients with Alzheimer's disease : Additional follow-up results of a pilot study through 1 year by MERRILL, Charley A, JONSSON, Michael A. G, BEN-MENACHEM, Elinor, SJÖGREN, Magnus J. C, MINTHON, Lennart, EJNELL, Hasse, SILANDER, Hans C-Son, BLENNOW, Kaj, KARLSSON, Mats, NORDLUND, Arto, ROLSTAD, Sindre, WARKENTIN, Siegbert

“…Cognitive-enhancing effects of vagus nerve stimulation (VNS) have been reported during 6 months of treatment in a pilot study of patients with Alzheimer's…”
Get full text

O3‐04‐08: Cerebral vascular encephalopathy causes decreased cerebrospinal Aβ concentrations by Verbeek, Marcel M., Spies, Petra E., Slats, Diane, Sjogren, Magnus J.C., Kremer, Berry P.H., Olde Rikkert, Marcel G.M., Greenberg, Steven M.

Get full text

Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study by Sjögren, Magnus J C, Hellström, Per T O, Jonsson, Michael A G, Runnerstam, Magnus, Silander, Hans C-Son, Ben-Menachem, Elinor

“…Vagus nerve stimulation (VNS) is an established treatment method for therapy-refractory epilepsy and, in Europe, for treatment-resistant depression also…”
Get full text

O3‐03‐07: Hourly variability of cerebrospinal fluid biomarkers in Alzheimer patients and healthy elderly controls by Slats, Diane, Spies, Petra E., Claassen, Jurgen A.H.R., Sjögren, Magnus J.C., Tseng, Jack, Verbeek, Marcel M., Olde Rikkert, Marcel G.M.

Get full text